Advanced Critical Devices, Inc. v. Boston Scientific Corporation

CourtDistrict Court, N.D. Ohio
DecidedApril 28, 2022
Docket1:21-cv-02227
StatusUnknown

This text of Advanced Critical Devices, Inc. v. Boston Scientific Corporation (Advanced Critical Devices, Inc. v. Boston Scientific Corporation) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Advanced Critical Devices, Inc. v. Boston Scientific Corporation, (N.D. Ohio 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION

ADVANCED CRITICAL DEVICES, INC., CASE NO. 1:21-CV-02227

Plaintiff, -vs- JUDGE PAMELA A. BARKER

BOSTON SCIENTIFIC CORPORATION, MEMORANDUM OPINION AND Defendant. ORDER

Currently pending is Defendant Boston Scientific Corporation’s (“BSC”) Motion to Transfer Venue Pursuant to 28 U.S.C. § 1404(a). (Doc. No. 9.) Plaintiff Advanced Critical Devices, Inc. (“ACD”) filed an Opposition Memorandum on February 7, 2022, to which BSC replied on February 14, 2022. (Doc. Nos. 12, 17.) On February 16, 2022, ACD filed a Motion for Leave to File Sur- reply Brief. (Doc. No. 18.) BSC opposed ACD’s request on February 17, 2022. (Doc. No. 20.) ACD filed a Reply in support of its request on February 22, 2022. (Doc. No. 21.) For the following reasons, BSC’s Motion to Transfer Venue is denied. ACD’s Motion for Leave to File Sur-reply Brief is denied. I. Background ACD is an Ohio corporation, and its principal place of business is in Brecksville, Ohio. (Doc. No. 15, ¶ 2.) ACD is engaged in the business of distributing specialty medical products throughout Ohio and other territories within the United States. (Id.) Under the terms of various distribution agreements, ACD distributed certain “cryoablation” products within a specified multi-state territory on behalf of third-party Galil Medical, Inc. (Id. at ¶ 10.) The most recent distribution agreement between ACD and Galil is dated July 1, 2019 (the “Distribution Agreement”). (Id.) The Distribution Agreement has a forum-selection clause that provides as follows: 27 Governing Law and Jurisdiction

27.1 This Agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of or in any way relating to this Agreement or its promotion) shall be governed by and construed in accordance with Minnesota law. Each of the Parties to this Agreement hereby irrevocably submits to the exclusive jurisdiction of the state or federal courts of Minnesota for the determination of any question or dispute arising in connection with this Agreement (including without limitation, claims for set-off or counterclaims).

(Doc. No. 9-3, ¶ 27.) In August 2019, through a series of mergers and acquisitions, BSC became the successor-in- interest to Galil’s rights and obligations under the Distribution Agreement with ACD. (Doc. No. 15, ¶ 12.) Approximately 18 months thereafter, by letter dated February 23, 2021, BSC provided ACD with the contractually required nine months’ notice that BSC was terminating its Distribution Agreement with ACD. (Id. at ¶ 13.) Shortly thereafter, in March 2021, BSC notified ACD that, notwithstanding the nine months’ notice required under the Distribution Agreement, BSC intended to transition some or all of ACD’s accounts well in advance of the nine months’ notice expiration period. (Id. at ¶ 14.) After some negotiating, the parties entered into a Transition Services Agreement (the “TSA”) in July 2021. (Id. at ¶ 16.) According to the TSA, ACD agreed to perform certain transition services for BSC and deliver “Transition Letters” to its customers, announcing the transition of sales and services from ACD to BSC. (Id. at ¶ 17.) In return, BSC agreed to compensate ACD $10,000 (or $25,000 with respect to eight (8) identified accounts) for each acknowledged Transition Letter that it provided to BSC, up to a maximum of $1,000,000 in transition payments. (Id. at ¶ 18.) According 2 to the TSA, the delivery of each Transition Letter to BSC deems the account transition completed and gives rise to BSC’s obligation to pay ACD the applicable Transition Payment. (Id. at ¶ 19.) ACD alleges that the TSA expressly provides that “the Transition Payments are due ‘in the month immediately following each month in which an account transition is deemed completed.’ [Exh. 1, Paragraph 4.1][.]” (Id. at ¶ 20.) ACD alleges that in September and October of 2021, it provided BSC with acknowledged Transition Letters entitling Plaintiff to $425,000.00 in Transition Payments

to be paid on or before October 31, 2021 and $575,000 in Transition Payments to be paid on or before November 30, 2021, but that BSC filed to make these payments totaling $1,000,000.00. (Id. at ¶¶ 21-24.) The TSA also contained a forum-selection clause, which provides as follows: 16. Governing law. This Agreement shall be construed in accordance with and governed by the law applicable in the jurisdiction where Company is located, and the parties agree to the exclusive jurisdiction of the courts in such jurisdiction. (Doc. No. 9-1, PageID# 143.) The TSA defines “Company” as “Boston Scientific Corporation, a Delaware corporation having its offices at 300 Boston Scientific Way, Marlborough, MA, 01752 (‘Company’).” (Id. at PageID# 139.) On November 23, 2021, ACD filed a complaint against BSC asserting a breach of contract claim and an unjust enrichment claim.1 (See Doc. No. 1.) On January 24, 2021, BSC filed an Answer to the complaint. (Doc. No. 8.) The same day, BSC also filed the instant Motion to Transfer Venue. (Doc. No. 9.) Therein, BSC seeks to enforce the TSA’s forum-selection clause and moves the Court to transfer this case to the United States District Court of Minnesota, pursuant to 28 U.S.C. § 1404(a).

1 ACD filed its First Amended Complaint on February 14, 2022, in which it alleges that BSC failed to make both the October 2021 and November 2021 transition payments to ACD. (See Doc No. 15.) When ACD filed its initial complaint, the time had not yet expired for BSC to make its November 2021 payment to ACD. 3 (Id. at PageID# 125.) On February 7, 2022, ACD filed its Opposition to BSC’s Motion, to which BSC replied on February 14, 2022. (Doc. Nos. 12, 17.) On February 16, 2022, ACD filed a Motion for Leave to File Sur-reply Brief, asserting that it should be allowed the opportunity to address allegedly “novel” issues raised in BSC’s Reply brief. (Doc. No. 18, PageID# 282.) On February 17, 2022, BSC filed an Opposition to ACD’s Motion for Leave to File Sur-reply, to which ACD replied on February 22, 2022. (Doc. Nos. 20, 21.)

II. Motion for Leave to File Sur-reply In ACD’s Motion for Leave to File Sur-Reply Brief, ACD requests leave to file a sur-reply and its own affidavits to respond to arguments raised in BSC’s Reply that ACD contends were not raised in the original Motion. (Doc. No. 18.) In opposing ACD’s request, BSC asserts that it did not raise any new arguments in its Reply but simply responded to arguments that ACD raised in its Opposition. (Doc. No. 20.) The Court finds that ACD seeks to set forth arguments in its sur-reply that could have been raised, or were raised, in its Opposition. “Although the Federal Rules of Civil Procedure do not expressly permit the filing of sur- replies, such filings may be allowed in the appropriate circumstances, especially ‘[w]hen new submissions and/or arguments are included in a reply brief, and a nonmovant’s ability to respond to

the new evidence has been vitiated.’” Key v. Shelby Cty., 551 F. App’x 262, 265 (6th Cir. 2014) (quoting Seay v. Tenn. Valley Auth., 339 F.3d 454, 481 (6th Cir. 2003)); accord Eldridge v. Cardif Life Ins. Co., 266 F.R.D. 173, 175 (N.D. Ohio 2010) (“This Court grants leave to file a sur-reply to afford a party an opportunity to address new issues raised for the first time in the reply.”). On the other hand, when a reply does not include new arguments or evidence, a sur-reply is “an

Free access — add to your briefcase to read the full text and ask questions with AI

Related

The Bremen v. Zapata Off-Shore Co.
407 U.S. 1 (Supreme Court, 1972)
Firestone Tire & Rubber Co. v. Bruch
489 U.S. 101 (Supreme Court, 1989)
William L. Smith v. Abs Industries, Inc.
890 F.2d 841 (Sixth Circuit, 1990)
In Re Delta America Re Insurance Co.
900 F.2d 890 (Sixth Circuit, 1990)
Valspar Refinish, Inc. v. Gaylord's, Inc.
764 N.W.2d 359 (Supreme Court of Minnesota, 2009)
Wong v. PartyGaming Ltd.
589 F.3d 821 (Sixth Circuit, 2009)
Motorsports Racing Plus, Inc. v. Arctic Cat Sales, Inc.
666 N.W.2d 320 (Supreme Court of Minnesota, 2003)
Picker International, Inc. v. Travelers Indemnity Co.
35 F. Supp. 2d 570 (N.D. Ohio, 1998)
Hanson Engineers Inc. v. Uneco, Inc.
64 F. Supp. 2d 797 (C.D. Illinois, 1999)
Jacqueline Key v. Shelby County
551 F. App'x 262 (Sixth Circuit, 2014)
Graham v. Drydock Coal Co.
667 N.E.2d 949 (Ohio Supreme Court, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Advanced Critical Devices, Inc. v. Boston Scientific Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/advanced-critical-devices-inc-v-boston-scientific-corporation-ohnd-2022.